Mirati Therapeutics (NASDAQ:MRTX) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of Mirati Therapeutics (NASDAQ:MRTX – Free Report) in a report released on Tuesday. The brokerage issued a sell rating on the biotechnology company’s stock. Several other equities analysts also recently commented on MRTX. BMO Capital Markets upped their price objective on shares of Mirati Therapeutics from $31.00 to $72.00 and […]
More Stories
Blue Foundry Bancorp (BLFY) Expected to Announce Quarterly Earnings on Wednesday
Blue Foundry Bancorp (NASDAQ:BLFY – Get Free Report) will likely be releasing its earnings data before the market opens on...
Novozymes A/S (OTCMKTS:NVZMF) Share Price Crosses Below Fifty Day Moving Average – Here’s What Happened
Shares of Novozymes A/S (OTCMKTS:NVZMF – Get Free Report) crossed below its 50-day moving average during trading on Monday ....
The Gym Group (LON:GYM) Shares Cross Below Fifty Day Moving Average – Time to Sell?
The Gym Group plc (LON:GYM – Get Free Report) shares passed below its 50 day moving average during trading on...
The Baillie Gifford Japan Trust (LON:BGFD) Share Price Crosses Below 50 Day Moving Average – Here’s Why
The Baillie Gifford Japan Trust PLC (LON:BGFD – Get Free Report) shares passed below its fifty day moving average during...
Knight-Swift Transportation (KNX) Expected to Announce Earnings on Wednesday
Knight-Swift Transportation (NYSE:KNX – Get Free Report) is anticipated to announce its earnings results after the market closes on Wednesday,...
Farmers National Banc (FMNB) Projected to Post Quarterly Earnings on Wednesday
Farmers National Banc (NASDAQ:FMNB – Get Free Report) is projected to release its earnings data before the market opens on...